Literature DB >> 11199918

From BILAG to BLIPS--disease activity assessment in lupus past, present and future.

D A Isenberg1, C Gordon.   

Abstract

During the past 16 years, members of the British Isles Lupus Assessment Group (BILAG) have met on a regular basis and have been instrumental in devising a comprehensive disease activity index and, in association with others in the international rheumatological community, devising and/or testing damage and patients self-assessment indices. The history of what the BILAG group has achieved is set out here and the latest attempts at computerisation and improvements in the Disease Activity Index itself are described.

Entities:  

Mesh:

Year:  2000        PMID: 11199918     DOI: 10.1191/096120300672904669

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  21 in total

1.  Belimumab (benlysta): a breakthrough therapy for systemic lupus erythematosus.

Authors:  Raymond Lamore; Sapna Parmar; Khilna Patel; Olga Hilas
Journal:  P T       Date:  2012-04

2.  The efficacy and safety of rituximab in a chart review study of 15 patients with systemic lupus erythematosus.

Authors:  R A Hickman; R Hira-Kazal; C-S Yee; V Toescu; Caroline Gordon
Journal:  Clin Rheumatol       Date:  2015-01-08       Impact factor: 2.980

3.  A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.

Authors:  Richard Furie; Michelle Petri; Omid Zamani; Ricard Cervera; Daniel J Wallace; Dana Tegzová; Jorge Sanchez-Guerrero; Andreas Schwarting; Joan T Merrill; W Winn Chatham; William Stohl; Ellen M Ginzler; Douglas R Hough; Z John Zhong; William Freimuth; Ronald F van Vollenhoven
Journal:  Arthritis Rheum       Date:  2011-12

4.  Prevalence and predictors of fragility fractures in systemic lupus erythematosus.

Authors:  C-S Yee; N Crabtree; J Skan; N Amft; S Bowman; D Situnayake; C Gordon
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

Review 5.  B-cell survival factors in autoimmune rheumatic disorders.

Authors:  Sandra A Morais; Andreia Vilas-Boas; David A Isenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

6.  A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.

Authors:  Daniel J Wallace; William Stohl; Richard A Furie; Jeffrey R Lisse; James D McKay; Joan T Merrill; Michelle A Petri; Ellen M Ginzler; W Winn Chatham; W Joseph McCune; Vivian Fernandez; Marc R Chevrier; Z John Zhong; William W Freimuth
Journal:  Arthritis Rheum       Date:  2009-09-15

7.  Novel evidence-based systemic lupus erythematosus responder index.

Authors:  Richard A Furie; Michelle A Petri; Daniel J Wallace; Ellen M Ginzler; Joan T Merrill; William Stohl; W Winn Chatham; Vibeke Strand; Arthur Weinstein; Marc R Chevrier; Z John Zhong; William W Freimuth
Journal:  Arthritis Rheum       Date:  2009-09-15

Review 8.  Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).

Authors:  Juanita Romero-Diaz; David Isenberg; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

9.  Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

Authors:  Joan T Merrill; C Michael Neuwelt; Daniel J Wallace; Joseph C Shanahan; Kevin M Latinis; James C Oates; Tammy O Utset; Caroline Gordon; David A Isenberg; Hsin-Ju Hsieh; David Zhang; Paul G Brunetta
Journal:  Arthritis Rheum       Date:  2010-01

10.  Numerical scoring for the Classic BILAG index.

Authors:  Lynne Cresswell; Chee-Seng Yee; Vernon Farewell; Anisur Rahman; Lee-Suan Teh; Bridget Griffiths; Ian N Bruce; Yasmeen Ahmad; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; Veronica Toescu; David D'Cruz; Munther A Khamashta; Peter Maddison; David A Isenberg; Caroline Gordon
Journal:  Rheumatology (Oxford)       Date:  2009-09-24       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.